In a French randomized trial, children at school-age demonstrated no evidence of harm from
fetal exposure to MgSO 4 before very preterm birth. Motor dysfunction/death, qualitative …

METHODS Overall, 573 women with fetuses of< 33 weeks' gestation whose birth was
planned within 24 hours were enrolled in 13 tertiary hospitals from 1997 to 2003, with 286 …

METHODS OF STUDY SELECTION: Randomized controlled trials comparing magnesium
sulfate with placebo/other treatment in patients at risk of preterm delivery were evaluated for …

Objective To evaluate whether magnesium sulphate (MgSO4) given to women at risk of very‐
preterm birth would be neuroprotective in preterm newborns and would prevent neonatal …

ContextPrenatal magnesium sulfate may reduce the risk of cerebral palsy or death in very
preterm infants. ObjectiveTo determine the effectiveness of magnesium sulfate given for …

Importance Antenatal magnesium sulfate given to pregnant women at imminent risk of very
preterm delivery reduces the risk of cerebral palsy in early childhood, although its effects into …

Effects and Safety of Magnesium Sulfate on Neuroprotection:... : Medicine Effects and Safety of
Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines …

Antenatal magnesium sulfate and neuroprotection : Current Opinion in Pediatrics Antenatal
magnesium sulfate and neuroprotection : Current Opinion in Pediatrics Log in or Register …

Despite improvements in perinatal care, preterm birth still occurs regularly and the
associated brain injury and adverse neurological outcomes remain a persistent challenge …

OBJECTIVE: To systematically review rates of neurologic outcomes reported in childhood for
the preterm fetus exposed to antenatal magnesium sulfate. DATA SOURCES: We searched …